The latest people news happenings over the past month.
ArisGlobal, a drug development software company, is expanding its executive team with the addition of Ann-Marie Orange as the company’s CTO and Glenn Renzulli as CFO. Bringing over 25 years of experience in senior technology roles across several sectors and geographies, including her recent 8+ year tenure at TransUnion as the CIO for Europe, Orange will be responsible for technology strategy, architecture, and product development. Upon joining, she brings ArisGlobal’s women in C-suite positions to 33%. As for Renzulli, prior to joining ArisGlobal, he was the CFO of Paya, where he helped lead the team through a public listing and an eventual sale to Nuvei Corporation.
Closed Loop Medicine Ltd., a techbio company developing combination prescription drug plus software therapy products that enable personalized dose optimization, has appointed Kate Woolland as COO. She joins CEO, Hakim Yadi PhD, on the executive team to guide organizational and operational delivery of the company’s lead programs, products, and commercial partnerships. In her previous role, Woolland was chief delivery officer at ieso, a digital mental healthcare and therapeutics business, where she led product, design, clinical trial operations, commercial, regulatory and program management functions.
Independent Pharmacy Cooperative (IPC), a group purchasing organization, has promoted Darren Thieding to the role of COO. Thieding, who leads IPC's Sales, marketing, and membership teams, will now oversee the cooperative's distribution operations. He will continue to report directly to Marc Essensa, IPC’s president and CEO.
Abzena, a contract development and manufacturing organization (CDMO), has brought on Thomas Castellano as its CFO. He has more than 20 years of experience in corporate finance and capital markets, with a foundation in biotech industry finance. Castellano joins Abzena from the CDMO Catalent, where he spent 15 years in financial leadership roles of increasing responsibility, most recently as the company’s SVP and CFO.
The aforementioned Catalent is hiring Matti Masanovich to become is SVP & CFO, effective July 5. Before joining the CDMO, He served as EVP & CFO of Tenneco Automotive until it was acquired by Apollo. And previously. he was CFO at Superior Industries International and General Cable Corporation.
Everest Medicines, a biopharmaceutical company focused on development, manufacturing, and commercialization of medicines and vaccines, has appointed Mike Berry, PhD, as its CTO, effective immediately. He has more than 30 years of industrial experience in advancing projects, from pre-clinical development phase to commercial stage.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.